Squarepoint’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.17M Buy
+321,396
New +$6.92M 0.01% 1155
2026
Q1
Sell
-483,043
Closed -$6.8M 4772
2025
Q4
$6.94M Buy
+483,043
New +$8.36M 0.01% 1258
2025
Q3
Sell
-31,317
Closed -$516K 4808
2025
Q2
$671K Sell
31,317
-113,472
-78% -$1.69M ﹤0.01% 3018
2025
Q1
$1.9M Sell
144,789
-61,309
-30% -$910K ﹤0.01% 2137
2024
Q4
$2.77M Buy
206,098
+144,731
+236% +$2.33M ﹤0.01% 2126
2024
Q3
$1.3M Sell
61,367
-81,283
-57% -$1.46M ﹤0.01% 2398
2024
Q2
$2.26M Buy
142,650
+31,990
+29% +$588K ﹤0.01% 1960
2024
Q1
$1.65M Sell
110,660
-22,053
-17% -$302K ﹤0.01% 2221
2023
Q4
$1.21M Buy
+132,713
New +$916K ﹤0.01% 2389
2023
Q3
Sell
-61,599
Closed -$496K 4112
2023
Q2
$496K Buy
61,599
+41,669
+209% +$307K ﹤0.01% 2622
2023
Q1
$130K Sell
19,930
-2,328
-10% -$9.5K ﹤0.01% 2919
2022
Q4
$54.8K Buy
+22,258
New +$69.6K ﹤0.01% 3044
2022
Q1
Sell
-72,208
Closed -$567K 3332
2021
Q4
$567K Buy
+72,208
New +$907K ﹤0.01% 2061

Other funds holding OSCR

Squarepoint's OSCR Position: Q2 2026 in Review

Squarepoint opened a new position in Oscar Health (OSCR) in Q2 2026: 321,396 shares worth $9.17M. The stake represents 0.01% of the portfolio and ranks #1155 among its holdings. This is a return to the name: Squarepoint previously reported a position in OSCR as recently as Q4 2025.

Squarepoint first reported a position in OSCR in Q4 2021 and has held it in 13 quarters since. 403 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Squarepoint held 321,396 shares of Oscar Health worth $9.17M as of Q2 2026.
  • Oscar Health was a new Squarepoint position in Q2 2026.
  • Oscar Health made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1155 holding.
  • Squarepoint first reported a position in Oscar Health in Q4 2021 and has held it in 13 quarters since.
  • 403 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.